[HTML][HTML] An update on breast cancer chemotherapy-associated toxicity and their management approaches
As the incidence rate of breast cancer is increasing at an alarming rate these days, this is
leading to an increase in the use of chemotherapy drugs. Here we used a systematic review …
leading to an increase in the use of chemotherapy drugs. Here we used a systematic review …
Paclitaxel-induced dorsal hand-foot syndrome
EY Quan, C Engel, PS Rush… - Dermatology Online …, 2023 - escholarship.org
Hand-foot syndrome (HFS), also known as palmoplantar erythrodysesthesia or acral
erythema, is a known adverse effect of chemotherapeutic agents that most commonly …
erythema, is a known adverse effect of chemotherapeutic agents that most commonly …
[HTML][HTML] Dermatological Aspects of Nursing Oncology: Meaningful Observations Ensuring Better Quality of Life
A Maheshwari, A Shankar, K Tyagi… - Indian Journal of …, 2022 - ncbi.nlm.nih.gov
Modern cancer management has changed over the period of time and now shifted to
multidisciplinary care approach to ensure a better quality of life (QOL) of the surfing patients …
multidisciplinary care approach to ensure a better quality of life (QOL) of the surfing patients …
Tyrosine kinase inhibitor nilotinib induced palmoplantar erythrodysesthesia: A rare case
M Aslaner Ak, P Ertop Doğan… - Journal of Oncology …, 2022 - journals.sagepub.com
Introduction Nilotinib is a second generation Tyrosine Kinase inhibitor (TKI) used in the
treatment of Chronic Myeloid Leukemia (CML). The development of tyrosine kinase …
treatment of Chronic Myeloid Leukemia (CML). The development of tyrosine kinase …